299 related articles for article (PubMed ID: 30305100)
21. Tunneling nanotube-transmitted mechanical signal and its cellular response.
Wang Y; Han X; Deng L; Wang X
Biochem Biophys Res Commun; 2024 Jan; 693():149368. PubMed ID: 38091838
[TBL] [Abstract][Full Text] [Related]
22. RalGPS2 is involved in tunneling nanotubes formation in 5637 bladder cancer cells.
D'Aloia A; Berruti G; Costa B; Schiller C; Ambrosini R; Pastori V; Martegani E; Ceriani M
Exp Cell Res; 2018 Jan; 362(2):349-361. PubMed ID: 29208460
[TBL] [Abstract][Full Text] [Related]
23.
Lou E
Front Oncol; 2020; 10():559548. PubMed ID: 33324545
[TBL] [Abstract][Full Text] [Related]
24. Structural and functional analysis of tunneling nanotubes (TnTs) using gCW STED and gconfocal approaches.
Bénard M; Schapman D; Lebon A; Monterroso B; Bellenger M; Le Foll F; Pasquier J; Vaudry H; Vaudry D; Galas L
Biol Cell; 2015 Nov; 107(11):419-25. PubMed ID: 26094971
[TBL] [Abstract][Full Text] [Related]
25. Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesothelioma.
Sarkari A; Korenfeld S; Deniz K; Ladner K; Wong P; Padmanabhan S; Vogel RI; Sherer LA; Courtemanche N; Steer C; Wainer-Katsir K; Lou E
Elife; 2023 Nov; 12():. PubMed ID: 37955637
[TBL] [Abstract][Full Text] [Related]
26. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.
Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H
Oncol Rep; 2006 May; 15(5):1281-5. PubMed ID: 16596198
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
28. Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML).
Omsland M; Bruserud Ø; Gjertsen BT; Andresen V
Oncotarget; 2017 Jan; 8(5):7946-7963. PubMed ID: 27974700
[TBL] [Abstract][Full Text] [Related]
29. Myo10 is a key regulator of TNT formation in neuronal cells.
Gousset K; Marzo L; Commere PH; Zurzolo C
J Cell Sci; 2013 Oct; 126(Pt 19):4424-35. PubMed ID: 23886947
[TBL] [Abstract][Full Text] [Related]
30. Tumor-stromal cross talk: direct cell-to-cell transfer of oncogenic microRNAs via tunneling nanotubes.
Thayanithy V; Dickson EL; Steer C; Subramanian S; Lou E
Transl Res; 2014 Nov; 164(5):359-65. PubMed ID: 24929208
[TBL] [Abstract][Full Text] [Related]
31. Control of long-distance cell-to-cell communication and autophagosome transfer in squamous cell carcinoma via tunneling nanotubes.
Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Enciso E; García-Moreno I; Chiara JL; Suarez C; Chiara MD
Oncotarget; 2017 Mar; 8(13):20939-20960. PubMed ID: 28423494
[TBL] [Abstract][Full Text] [Related]
32. Tunneling nanotubes: emerging view of their molecular components and formation mechanisms.
Kimura S; Hase K; Ohno H
Exp Cell Res; 2012 Aug; 318(14):1699-706. PubMed ID: 22652450
[TBL] [Abstract][Full Text] [Related]
33. GFAP serves as a structural element of tunneling nanotubes between glioblastoma cells and could play a role in the intercellular transfer of mitochondria.
Simone L; Capobianco DL; Di Palma F; Binda E; Legnani FG; Vescovi AL; Svelto M; Pisani F
Front Cell Dev Biol; 2023; 11():1221671. PubMed ID: 37886397
[TBL] [Abstract][Full Text] [Related]
34. Identification and Characterization of Tunneling Nanotubes for Intercellular Trafficking.
Abounit S; Delage E; Zurzolo C
Curr Protoc Cell Biol; 2015 Jun; 67():12.10.1-12.10.21. PubMed ID: 26061240
[TBL] [Abstract][Full Text] [Related]
35. Effect of tolytoxin on tunneling nanotube formation and function.
Dilsizoglu Senol A; Pepe A; Grudina C; Sassoon N; Reiko U; Bousset L; Melki R; Piel J; Gugger M; Zurzolo C
Sci Rep; 2019 Apr; 9(1):5741. PubMed ID: 30952909
[TBL] [Abstract][Full Text] [Related]
36. Rab35 and its effectors promote formation of tunneling nanotubes in neuronal cells.
Bhat S; Ljubojevic N; Zhu S; Fukuda M; Echard A; Zurzolo C
Sci Rep; 2020 Oct; 10(1):16803. PubMed ID: 33033331
[TBL] [Abstract][Full Text] [Related]
37. Rho GTPases and the emerging role of tunneling nanotubes in physiology and disease.
Zhang S; Kazanietz MG; Cooke M
Am J Physiol Cell Physiol; 2020 Nov; 319(5):C877-C884. PubMed ID: 32845720
[TBL] [Abstract][Full Text] [Related]
38. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
39. Selective block of tunneling nanotube (TNT) formation inhibits intercellular organelle transfer between PC12 cells.
Bukoreshtliev NV; Wang X; Hodneland E; Gurke S; Barroso JF; Gerdes HH
FEBS Lett; 2009 May; 583(9):1481-8. PubMed ID: 19345217
[TBL] [Abstract][Full Text] [Related]
40. Tunneling nanotubes: Diversity in morphology and structure.
Austefjord MW; Gerdes HH; Wang X
Commun Integr Biol; 2014 Jan; 7(1):e27934. PubMed ID: 24778759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]